Monday, January 30, 2017

Gainers & Losers Of The Day: CALA, EVOK, EYEG, OCRX, TENX...

Calithera Biosciences Inc. (CALA) has entered into a collaboration with Incyte Corp. (INCY) to develop CB-1158, a phase I drug candidate.

from RTT - Biotech http://ift.tt/2joF48C
via IFTTT

No comments:

Post a Comment